Mitochondrial quality control proteases and their modulation for cancer therapy

J Zhang, W Qiao, Y Luo - Medicinal Research Reviews, 2023 - Wiley Online Library
Mitochondria, the main provider of energy in eukaryotic cells, contains more than 1000
different proteins and is closely related to the development of cells. However, damaged …

Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists

R Zhang, P Wang, B Wei, L Chen, X Song… - European Journal of …, 2023 - Elsevier
Human caseinolytic protease P (ClpP) is required for the regulatory hydrolysis of
mitochondrial proteins. Allosteric ClpP agonists dysfunctionally activate mitochondrial ClpP …

Ecological network analysis reveals cancer-dependent chaperone-client interaction structure and robustness

G Galai, X He, B Rotblat, S Pilosof - Nature Communications, 2023 - nature.com
Cancer cells alter the expression levels of metabolic enzymes to fuel proliferation. The
mitochondrion is a central hub of metabolic reprogramming, where chaperones service …

Feasibility and safety of targeting mitochondria for cancer therapy–preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule …

U Hayat, GT Elliott, AJ Olszanski… - Cancer biology & …, 2022 - Taylor & Francis
Mitochondria are key tumor drivers, but their suitability as a therapeutic target is unknown.
Here, we report on the preclinical characterization of Gamitrinib (GA mit ochondrial ma tri x …

Mitochondrial dysfunction in the pathophysiology of renal diseases

Y Guo, R Che, P Wang… - American Journal of …, 2024 - journals.physiology.org
Mitochondria are essential organelles in the human body, serving as the metabolic factory of
the whole organism. When mitochondria are dysfunctional, it can affect all organs of the …

Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives

J Lee, AK Pandey, S Venkatesh, J Thilagavathi… - Journal of Biological …, 2022 - ASBMB
The mitochondrial protein LonP1 is an ATP-dependent protease that mitigates cell stress
and calibrates mitochondrial metabolism and energetics. Biallelic mutations in the LONP1 …

Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators

Y Zhang, J Jiang, H Ding, Q Li, Y **ao, H Sun - Bioorganic Chemistry, 2024 - Elsevier
Based on a clinically staged small molecular hClpP activator ONC201, a class of imipridone
derivatives was designed and synthesized. These compounds were evaluated in a protease …

Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment

M Miciaccia, F Rizzo, A Centonze, G Cavallaro… - Pharmaceuticals, 2024 - mdpi.com
Diffuse intrinsic pontine glioma (DIPG), affecting children aged 4–7 years, is a rare,
aggressive tumor that originates in the pons and then spreads to nearby tissue. DIPG is the …

Proteasome localization and activity in pig brain and in vivo small molecule screening for activators

A Amrein Almira, MW Chen, N El Demerdash… - Frontiers in Cellular …, 2024 - frontiersin.org
Introduction Loss of proteasome function, proteinopathy, and proteotoxicity may cause
neurodegeneration across the human lifespan in several forms of brain injury and disease …

The Regulation of the Disease-Causing Gene FXN

YN Dong, E Mercado-Ayón, J Coulman, L Flatley… - Cells, 2024 - mdpi.com
Friedreich's ataxia (FRDA) is a progressive neurodegenerative disease caused in almost all
patients by expanded guanine–adenine–adenine (GAA) trinucleotide repeats within intron 1 …